跳至主要内容
临床试验/NCT07137780
NCT07137780已完成不适用

Lokomat® Versus RoboGait®: Comparative Effects on Walking, Mobility, and Quality of Life Under Different Guidance Force Settings in Motor-Incomplete Spinal Cord Injury

Ankara City Hospital Bilkent1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2022年11月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Walking Index in Spinal Cord Injury II

研究概览

简要总结

This study compares two robotic-assisted gait training systems, Lokomat® and RoboGait®, used under different guidance force (GF) settings, in people with motor-incomplete spinal cord injury (iSCI). Nineteen adults, aged 18 years or older, with injury at T3 level or below and classified as AIS C or D within two years of injury, participated. They were assigned to one of three groups based on the average GF used during training: Lok90- (GF < 90% with Lokomat®), Lok90+ (GF ≥ 90% with Lokomat®), and RG (GF ≥ 90% with RoboGait®). All participants completed 10 treadmill-based gait training sessions over 4 weeks, in addition to standard physiotherapy including stretching, strengthening, balance, and walking exercises. Walking ability, mobility, muscle strength, balance, independence in daily activities, and quality of life were assessed before and after the program. The study aimed to see whether the type of robot and GF setting affected recovery. Results showed modest improvements in some outcomes, with changes depending on the group and outcome measured. Findings suggest that adjusting GF settings may help tailor robotic gait training to individual needs.

详细描述

This pilot study investigated the effects of two robotic-assisted gait training systems, Lokomat® V6 (Hocoma AG, Switzerland) and RoboGait® (BAMA Teknoloji, Türkiye), applied under different guidance force (GF) settings, on walking ability, functional mobility, and health-related quality of life in individuals with motor-incomplete spinal cord injury (iSCI).

Eligible participants were aged 18 years or older, with injury at T3 level or below, AIS C or D classification, and injury duration of 2 years or less. Exclusion criteria included severe spasticity (Modified Ashworth Scale ≥ 3), joint disorders, implanted electronic devices, orthostatic hypotension, cardiac problems, or conditions preventing secure positioning in the robotic systems.

Participants were assigned to three groups according to their average GF during training: Lok90- (GF < 90% with Lokomat®), Lok90+ (GF ≥ 90% with Lokomat®), and RG (GF ≥ 90% with RoboGait®). All participants completed 10 treadmill-based gait training sessions over 4 weeks, with three sessions per week. Walking speed and angular parameters were individually adjusted to enhance comfort, reduce fatigue, and encourage active participation. Alongside robotic gait training, all participants received conventional physiotherapy that included stretching, strengthening, balance, walking, and mobility exercises.

The primary outcome was walking status, measured using the Walking Index for Spinal Cord Injury II (WISCI II). Secondary outcomes included, functional mobility (Timed Up and Go Test, TUG), lower extremity muscle strength (LEMS), balance (Berg Balance Scale, BBS), functional independence (Spinal Cord Independence Measure III, SCIM III), and health-related quality of life (WHOQOL-BREF-TR). The study aimed to determine whether the type of robotic system and GF settings influence functional outcomes in iSCI rehabilitation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults aged 18 years or older.
  • •Diagnosis of spinal cord injury (SCI) at T3 level or below.
  • •Injury duration of no more than 2 years.
  • •Functional classification of C or D based on the American Spinal Injury Association (ASIA) Impairment Scale.
  • •ICD-10 diagnosis codes between S24.73-S24.77 or S34.70

排除标准

  • •Participation in another study.
  • •Joint disorders affecting mobility.
  • •Implanted electronic devices.
  • •Orthostatic hypotension.
  • •Severe spasticity in the lower extremities (Modified Ashworth Scale score ≥ 3).
  • •Cardiac problems or conditions impairing stabilization in the robotic systems.
  • •Presence of a colostomy.

研究组 & 干预措施

Lok90- (GF < 90% with Lokomat®)

Experimental

Participants in this arm received robotic-assisted gait training using the Lokomat® V6 system (Hocoma AG, Switzerland) with an average guidance force (GF) of less than 90%. Training was conducted three times per week for 4 weeks, totaling 10 sessions. In addition to robotic gait training, participants also received conventional physiotherapy, including stretching, strengthening, balance, walking, and mobility exercises.

干预措施: Lokomat® V6 (GF < 90%) (Device)

Lok90+ (GF ≥ 90% with Lokomat®)

Experimental

Participants in this arm received robotic-assisted gait training using the Lokomat® V6 system (Hocoma AG, Switzerland) with an average guidance force (GF) of 90% or higher. Training was conducted three times per week for 4 weeks, totaling 10 sessions. In addition to robotic gait training, participants also received conventional physiotherapy, including stretching, strengthening, balance, walking, and mobility exercises.

干预措施: Lokomat® V6 (GF ≥ 90%) (Device)

RG (RoboGait®)

Experimental

Participants in this arm received robotic-assisted gait training using the RoboGait® system (BAMA Teknoloji, Türkiye) with an average guidance force (GF) of 90% or higher. Training was conducted three times per week for 4 weeks, totaling 10 sessions. In addition to robotic gait training, participants also received conventional physiotherapy, including stretching, strengthening, balance, walking, and mobility exercises.

干预措施: RoboGait® (Device)

结局指标

主要结局

Walking Index in Spinal Cord Injury II

时间窗: 24 months

Walking Index in Spinal Cord Injury II for walking independence level assessment

次要结局

  • Timed Up and Go Test(24 months)
  • Berg Balance Scale(24 months)
  • ASIA Lower Extremity Muscle Score(24 months)
  • Spinal Cord Independence Measure (SCIM III)(24 months)
  • World Health Organization Quality of Life Scale-Short Form (WHOQOL - BREF)(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验